Abstract Vitamin D modulates antimycobacterial immunity, and its deficiency has been implicated in susceptibility to nontuberculous mycobacterial pulmonary disease (NTM-PD). However, whether baseline vitamin D status influences treatment outcomes remains unclear. We analyzed 485 patients with available baseline serum 25-hydroxyvitamin D [25(OH)D] levels and 6-month culture data from a prospective multicenter cohort (NTM-KOREA) enrolled between April 2022 and August 2025.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Jake
Contact Jake, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack